Endocrine Society Part of Coalition That Developed New Osteoporosis, Fracture Treatment Guidelines

The Endocrine Society recently participated in a coalition of bone health experts, physicians, specialists, and patient advocacy groups to develop clinical care recommendations for the treatment of osteoporosis and resulting hip and spine fractures.

The Secondary Fracture Prevention: Consensus Recommendations from a Multistakeholder Coalition was published online in the peer-reviewed Journal of Bone and Mineral Research.

These recommendations outline the best course of clinical care for women and men, ages 65 years or older, with a hip or vertebral fracture, and emphasize that fracture patients should be managed in a multi-disciplinary clinical system to ensure appropriate evaluation and treatment for osteoporosis and risk of future fractures.

You may also like

  • More than Meets the Eye: Artificial Intelligence and X-Ray

    Due to the “fractured” process of treating osteoporosis, Australian researchers and software developers teamed up to create a tool that uses artificial intelligence to read X-rays. The new program —XRAIT — has significantly improved fracture detection and could change the future of osteoporosis treatment.  Christopher White, MBBS, PhD, FRACP, an endocrinologist at Prince of Wales…

  • Bone Health Experts Issue Osteoporosis Treatment Guidance During COVID-19

    As the COVID-19 pandemic became more serious, the Endocrine Society joined a coalition of bone health organizations that united to issue new osteoporosis treatment guidelines. Aside from addressing the challenges social distancing has placed on treating these patients, the coalition has also focused on the administration of osteoporosis medications including denosumab, teriparatide, abaloparatide, romosozumab, and…

Find more in